• search hit 59 of 1796
Back to Result List

Using, the simple sample count to estimate the frequency of prescription drug neuroenhancement in a sample of Jordan employees

  • Background: Epidemiological research indicates that the use of prescription drugs to enhance cognitive functioning is prevalent in Western countries, however, research on this phenomenon in Arab countries is lacking. Our study aimed to investigate the frequency of neuroenhancement (NE) using prescription drugs in a sample of employees in Jordan. Methods: A sample of 1186 employees (37.11 +/- 8.37 years old, 495 female), of whom 723 (35.65 +/- 7.53 years old, 396 female) served as teachers, completed a paper-pencil questionnaire. The single sample count technique (SSC) was used in order to secure confidential, self-reporting of prescription drug NE. Results: The 12-month prevalence of NE, estimated with the SSC was 15.43%. At 26.16%, the prevalence estimate was markedly higher in the subsample of teachers compared to non-teachers, 0.29%. Surprisingly, 336 participants did not use the SSC and directly affirmed or denied prescription drug NE. These direct responses yielded a prevalence of 11.57% for the full sample, 9.73% for theBackground: Epidemiological research indicates that the use of prescription drugs to enhance cognitive functioning is prevalent in Western countries, however, research on this phenomenon in Arab countries is lacking. Our study aimed to investigate the frequency of neuroenhancement (NE) using prescription drugs in a sample of employees in Jordan. Methods: A sample of 1186 employees (37.11 +/- 8.37 years old, 495 female), of whom 723 (35.65 +/- 7.53 years old, 396 female) served as teachers, completed a paper-pencil questionnaire. The single sample count technique (SSC) was used in order to secure confidential, self-reporting of prescription drug NE. Results: The 12-month prevalence of NE, estimated with the SSC was 15.43%. At 26.16%, the prevalence estimate was markedly higher in the subsample of teachers compared to non-teachers, 0.29%. Surprisingly, 336 participants did not use the SSC and directly affirmed or denied prescription drug NE. These direct responses yielded a prevalence of 11.57% for the full sample, 9.73% for the teachers and 15.60% for the non-teachers. Conclusion: This is the first study of the frequency of NE in an Arab sample. Results indicate that the use of prescription drug NE is not limited to Western countries and that teachers in Jordan might constitute a high-risk population. Further, participants seem to differ in their use of indirect estimation methods for reporting prescription drug NE. For future research, it might be useful to triangulate standard self reports and indirect estimation methods to assess NE. Possible cultural differences and specific high-risk populations for NE should be investigated further. (C) 2015 Elsevier B.V. All rights reserved.show moreshow less

Export metadata

Additional Services

Search Google Scholar Statistics
Metadaten
Author details:Wanja Wolff, Yaser Sandouqa, Ralf BrandORCiDGND
DOI:https://doi.org/10.1016/j.drugpo.2015.12.014
ISSN:0955-3959
ISSN:1873-4758
Pubmed ID:https://pubmed.ncbi.nlm.nih.gov/26818080
Title of parent work (English):International journal of drug policy
Publisher:Elsevier
Place of publishing:Amsterdam
Publication type:Article
Language:English
Year of first publication:2016
Publication year:2016
Release date:2020/03/22
Tag:Jordan; Neuroenhancement; Single sample count
Volume:31
Number of pages:5
First page:51
Last Page:55
Peer review:Referiert
Institution name at the time of the publication:Humanwissenschaftliche Fakultät / Exzellenzbereich Kognitionswissenschaften
Accept ✔
This website uses technically necessary session cookies. By continuing to use the website, you agree to this. You can find our privacy policy here.